CompletedPhase 3NCT00123916

BENEFIT: Evaluation of the Use of Antiparasital Drug (Benznidazole) in the Treatment of Chronic Chagas' Disease

Studying American trypanosomiasis

Last synced from ClinicalTrials.gov

ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Population Health Research Institute
Principal Investigator
Carlos Morillo, MD
Population Health Research Institute - McMaster University
Intervention
Benznidazole(drug)
Enrollment
2854 enrolled
Eligibility
18-75 years · All sexes
Timeline
2004 – 2015

Study locations (30)

Collaborators

Canadian Institutes of Health Research (CIHR) · World Health Organization · Instituto Dante Pazzanese de Cardiologia · University of Sao Paulo

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT00123916 on ClinicalTrials.gov

Other trials for American trypanosomiasis

Additional recruiting or active studies for the same condition.

See all trials for American trypanosomiasis →

← Back to all trials